A detailed history of Tema Etfs LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 14,960 shares of VYGR stock, worth $63,729. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,960
Holding current value
$63,729
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$5.27 - $8.07 $78,839 - $120,727
14,960 New
14,960 $84.8 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $165M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.